QDEL

Quidel

• Simply Wall St·1d ago

  Is It Time To Reassess QuidelOrtho (QDEL) After The Recent Share Price Slump?

• Simply Wall St·2d ago

  QuidelOrtho (QDEL) Valuation Check After Prolonged Share Price Weakness

• Reuters·03/31 20:21

  QuidelOrtho CLO Nathaniel Sisitsky files initial beneficial ownership statement

• Reuters·03/24 20:41

  QuidelOrtho EVP Global Portfolio Management and Marketing Bryan Michael Hanson files initial beneficial ownership statement

• TipRanks·03/24 11:32

  QuidelOrtho Announces Chief Legal Officer Leadership Transition

• Reuters·03/24 11:01

  QuidelOrtho names Nathaniel Sisitsky chief legal officer

• Dow Jones·03/24 11:00

  Press Release: Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer

• Dow Jones·03/24 11:00

  *Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer

• TipRanks·03/16 15:05

  Rising helium prices could create headwind for Bruker, says Jefferies

• Simply Wall St·03/02 15:15

  A Look At QuidelOrtho (QDEL) Valuation After New Lifotronic Supply Agreement

• TipRanks·02/27 11:30

  Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA)

• Simply Wall St·02/27 10:32

  Should QuidelOrtho’s (QDEL) Lifotronic Immunoassay Expansion Require Action From QDEL Investors?

• Simply Wall St·02/25 06:41

  Has QuidelOrtho (QDEL) Become A Potential Opportunity After Its Sharp Share Price Slide

• TipRanks·02/20 06:05

  Quidelortho Faces Material Risk from Weak Internal Controls and Sarbanes–Oxley Compliance Challenges

• Reuters·02/19 14:17

  QuidelOrtho Manager Says High-Sensitivity Troponin Speeds Heart Attack Diagnosis